Dynavax Technologies Files Definitive Proxy Materials
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | DEFA14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing
TL;DR
Dynavax dropped more proxy docs, check the letter they sent out.
AI Summary
Dynavax Technologies Corporation filed a DEFA14A on April 29, 2025, related to a press release concerning a letter distributed by the company. This filing is a definitive additional material, indicating it's not a preliminary proxy statement but rather supplementary information for shareholders. The company is based in Emeryville, California, and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides shareholders with additional information related to company communications, which is crucial for informed voting decisions at upcoming shareholder meetings.
Risk Assessment
Risk Level: low — This filing is a standard proxy statement update and does not contain information that inherently increases risk for investors.
Key Players & Entities
- DYNAVAX TECHNOLOGIES CORP (company) — Filer
- 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 (company) — Business and Mail Address
- 330728374 (company) — EIN
- 001-34207 (company) — SEC File Number
FAQ
What type of filing is this DEFA14A for Dynavax Technologies Corporation?
This DEFA14A filing is classified as 'Definitive Additional Materials'.
When was this filing submitted to the SEC?
The filing was submitted on April 29, 2025.
What is the primary business of Dynavax Technologies Corporation?
Dynavax Technologies Corporation is in the Pharmaceutical Preparations industry (SIC code 2834).
Where is Dynavax Technologies Corporation located?
The company's business and mail address is 2100 Powell Street, Suite 720, Emeryville, CA 94608.
What is the purpose of this filing according to the document?
This Schedule 14A filing consists of a press release relating to a letter distributed by Dynavax Technologies Corporation.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 29, 2025 regarding DYNAVAX TECHNOLOGIES CORP.